Abtak Logo

health-canada News

Stay updated with the latest health-canada news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on health-canada topics.

fallback-img
soure image
18
BusinessDec 16, 2025 03:54 PM

Senores Pharmaceuticals to Acquire Apnar Pharma Private Limited and Five ANDAs - APN News | Authenti...

Ahmedabad -- Senores Pharmaceuticals Limited today announced that it has entered into a definitive agreement to acquire 100% equity stake in Apnar Pharma Private Limited ("Apnar Pharma"), along with the acquisition of five Abbreviated New Drug Applications (ANDAs), marking a significant milestone in Senores' growth strategy across regulated pharmaceutical markets. Apnar Pharma, incorporated on December 12, 2014, is a privately held pharmaceutical company engaged in the licensing, development, a ...Read More >

NewsDrum - Business - News Image
soure image
12
BusinessOct 16, 2025 10:50 AM

Rubicon Research shares jump nearly 28 pc in market debut trade

New Delhi, Oct 16 (PTI) Shares of pharmaceutical company Rubicon Research Ltd on Thursday listed with a premium of nearly 28 per cent against the issue price of Rs 485. The stock started trading at Rs 620.10, up 27.85 per cent, from the issue price on the BSE. At the NSE, the stock made its debut at Rs 620, registering a jump of 27.83 per cent. The company's market valuation stood at Rs 9,917.97 crore. The initial public offer of Rubicon Research garnered 103.90-times subscription on the clo ...Read More >

NewsDrum - Business Health - News Image
soure image
30
BusinessHealthJun 27, 2025 01:17 PM

Biocon Biologics gets Health Canada nod for biosimilar Yesafili

New Delhi, Jun 27 (PTI) Biocon Ltd on Friday said its arm Biocon Biologics has been granted a notice of compliance by Health Canada for its biosimilar Yesafili injection used to treat various ailments of the eye. "Health Canada has granted a Notice of Compliance (NOC) for Yesafili(aflibercept), a biosimilar to Eylea injection, in vial and prefilled syringe presentations, 2 mg/0.05 mL on June 26, 2025," a regulatory filing by Biocon said. This approval paves the way for the launch of Yesafili i ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.